The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetic (PK) subgroup results from the phase 2 pharmacodynamic and bioequivalence study of abiraterone acetate fine particle formulation (AAFP) in patients with metastatic castration-resistant prostate cancer (mCRPC): The STAAR study.
 
Curtis Dunshee
Research Funding - Astellas Medivation (Inst); Churchill Pharmaceuticals (Inst); Dendreon (Inst); Ferring (Inst); Janssen Oncology (Inst); pfizer (Inst)
 
Cy Aaron Stein
Honoraria - ProQR
Consulting or Advisory Role - Churchill Pharmaceuticals; ProQR; Roche
Speakers' Bureau - Medivation; Pfizer; Sanofi
Research Funding - Roche
 
Paul R. Nemeth
Employment - Churchill Pharmaceuticals
Stock and Other Ownership Interests - Johnson & Johnson; Lilly; Pfizer
Research Funding - Churchill Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Churchill Pharmaceuticals
Travel, Accommodations, Expenses - Churchill Pharmaceuticals
 
Bill Bosch
Employment - Churchill Pharmaceuticals; iCeutica
Leadership - Botanix Pharma
Stock and Other Ownership Interests - various
Patents, Royalties, Other Intellectual Property - iCeutica
 
Jillian Chapas-Reed
Employment - iCeutica
 
Robert Dreicer
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Exelixis; Genentech/Roche; Genzyme; Medivation
Research Funding - Asana Biosciences (Inst); Genentech (Inst)